A review of 91 canine and feline red-bellied black snake (Pseudechis porphyriacus) envenomation cases and lessons for improved management
- PMID: 35318641
- PMCID: PMC9542610
- DOI: 10.1111/avj.13159
A review of 91 canine and feline red-bellied black snake (Pseudechis porphyriacus) envenomation cases and lessons for improved management
Abstract
Introduction: Most cases of red-bellied black snake (RBBS) envenomation in dogs respond favourably to treatment comprising of tiger-brown snake antivenom (TBAV), intravenous fluid therapy, analgesia and, if indicated, mechanical ventilation and/or blood transfusion. However, there remains a subset of patients who develop fatal complications despite intensive treatment and risk factors for these occurring remain unknown. Here we present a retrospective cross-sectional survey of 91 canine and feline RBBS envenomation cases.
Methods: Cases seen between June 2010 and June 2020 were retrieved from the databases of seven practices in South East and coastal Queensland. From the canine case population, logistic regression analysis was performed to assess the impact of potential risk factors at presentation on the likelihood of death. A final multivariable model was developed using a manual backwards elimination approach based on overall likelihood ratio tests and Wald chi-square P-values for each variable. Where model convergence failed due to quasi-complete separation, Firth's penalised maximum likelihood method was implemented. Such separation may occur when an outcome is completely predicted by an explanatory variable in one group.
Results: Of the 88 canine cases, 7 died (8.0%), all after prognosis-based euthanasia. Of the three feline cases, one died after unsuccessful resuscitation following cardiopulmonary arrest. Compared to survivors, dogs that died were older, exhibited pigmenturia, received antivenom later and had a higher total plasma protein (TPP), activated clotting time (ACT) and lower packed cell volume (PCV) at presentation.
Keywords: Pseudechis porphyriacus; acute kidney injury; dog; red-bellied black snake; snake envenomation; veterinary.
© 2022 The Authors. Australian Veterinary Journal published by John Wiley & Sons Australia, Ltd on behalf of Australian Veterinary Association.
Conflict of interest statement
The Padula® TBAV used in this study were manufactured by Dr Andrew Padula of Padula Serums Pty Ltd, Australia.
Figures
References
-
- Shea G. The distribution and identification of dangerously venomous Australian terrestrial snakes. Aust Vet J 1999;77:791–798. - PubMed
-
- Padula AM, Winkel KD. Red‐bellied black snake (Pseudechis porphyriacus) envenomation in the dog: diagnosis and treatment of nine cases. Toxicon 2016;117:69–75. - PubMed
-
- Finney E, Padula A, Leister E. Red‐bellied black snake (Pseudechis porphyriacus) envenomation in 17 dogs: clinical signs, coagulation changes, haematological abnormalities, venom antigen levels and outcomes following treatment with a tiger‐brown snake antivenom. Aust Vet J 2020;98:319–325. - PubMed
-
- Heller J, Bosward K, Hodgson J et al. Snake envenomation in dogs in New South Wales. Aust Vet J 2005;83:286–292. - PubMed
-
- Vaughan GT, Sculley TB, Tirrell R. Isolation of a hemolytic, toxic phospholipase from the venom of the Australian red‐bellied black snake (Pseudechis porphyriacus). Toxicon 1981;19:95–101. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
